In the current multicenter study, the ASAP score demonstrated comparable diagnostic ability to the GALAD score among HCVinfected patients for HCC detection; in addition, the ASAP score had better ability than any individual biomarkers including AFP, PIVKA-II and AFP‐L3%. This evidence concerns the gene AFP and hepatocellular carcinoma.